These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9165224)

  • 1. Insulin mediators in man: effects of glucose ingestion and insulin resistance.
    Shashkin PN; Shashkina EF; Fernqvist-Forbes E; Zhou YP; Grill V; Katz A
    Diabetologia; 1997 May; 40(5):557-63. PubMed ID: 9165224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs).
    Elased KM; Gumaa KA; de Souza JB; Rahmoune H; Playfair JH; Rademacher TW
    Mol Genet Metab; 2001 Jul; 73(3):248-58. PubMed ID: 11461192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating factors and insulin resistance. I. A novel myoinositol 1,2-cyclic phosphate phosphoglycan insulin antagonist from human plasma is elevated in noninsulin-dependent diabetes mellitus.
    Galasko GT; Bao Y; Broomfield SJ; Hooper NM; Turner AJ; Larner J
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2419-29. PubMed ID: 7629237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating factors and insulin resistance. II. The action of the novel myo-inositol cyclic 1,2-inositol phosphate phosphoglycan insulin antagonist from human plasma in regulating pyruvate dehydrogenase phosphatase.
    Galasko GT; Abe S; Lilley K; Zhang C; Larner J
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1051-7. PubMed ID: 8772575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inositol phosphoglycans and the regulation of the secretion of leptin: in vitro effects on leptin release from adipocytes and the relationship to obesity.
    Kunjara S; Wang DY; McLean P; Greenbaum AL; Rademacher TW
    Mol Genet Metab; 2000 May; 70(1):61-8. PubMed ID: 10833332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
    Burén J; Lindmark S; Renström F; Eriksson JW
    Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo.
    Huang LC; Fonteles MC; Houston DB; Zhang C; Larner J
    Endocrinology; 1993 Feb; 132(2):652-7. PubMed ID: 8425485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inositolphosphoglycans (IPGs) as mediators of insulin's steroidogenic actions.
    Nestler JE
    J Basic Clin Physiol Pharmacol; 1998; 9(2-4):197-204. PubMed ID: 10212834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus.
    Scioscia M; Gumaa K; Selvaggi LE; Rodeck CH; Rademacher TW
    J Perinat Med; 2009; 37(5):469-71. PubMed ID: 19492925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic and peripheral insulin resistance as a cause of hyperglycemia in non-insulin-dependent (type 2) diabetes mellitus: a review].
    Bratusch-Marrain P; Waldhäusl W
    Wien Klin Wochenschr; 1987 Apr; 99(7):211-6. PubMed ID: 3296467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies.
    Scioscia M; Gumaa K; Whitten M; Selvaggi LE; Rodeck CH; Rademacher TW
    J Reprod Immunol; 2007 Dec; 76(1-2):85-90. PubMed ID: 17493685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inositol phosphoglycan putative insulin mediator in human amniotic fluid.
    Scioscia M; Vimercati A; Selvaggi LE; Rodeck CH; Rademacher TW
    J Matern Fetal Neonatal Med; 2006 Jan; 19(1):9-12. PubMed ID: 16492584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels.
    Kunjara S; Greenbaum AL; Wang DY; Caro HN; McLean P; Redman CW; Rademacher TW
    Mol Genet Metab; 2000 Feb; 69(2):144-58. PubMed ID: 10720442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone Therapy Increases Insulin-Stimulated Release of d-Chiro-Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome.
    Gupta A; Jakubowicz D; Nestler JE
    Metab Syndr Relat Disord; 2016 Oct; 14(8):391-396. PubMed ID: 27028341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
    Márquez L; González N; Puente J; Valverde L; Villanueva-Peñacarrillo ML
    Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects.
    Asplin I; Galasko G; Larner J
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5924-8. PubMed ID: 8392181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.